The factors affecting effectiveness of treatment in phages therapy

Frontiers in Microbiology

Volumn 5, Issue FEB, 2014, Pages

  Ly Chatain, Mai Huong ^a  

^a ISARA Lyon   (France)

Author keywords

Antibiotic resistance; Effectiveness; Pathogenic bacteria; Phage; Phage therapy

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; DISEASE TRANSMISSION; FOOD INDUSTRY; NONHUMAN; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; XANTHOMONAS CAMPESTRIS;

EID: 84897625821     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00051     Document Type: Short Survey

References (51)

1. Berchieri, A. Jr., Lovell, M. A., and Barrow, P. A. (1991). The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142, 541-549. doi: 10.1016/0923-2508(91)90187-F
2. Bigot, B., Lee, W.-J., McIntyre, L., Wilson, T., Hudson, J. A., Billington, C., et al. (2011). Control of Listeria monocytogenes growth in a ready-to-eat poultry product using a bacteriophage. Food Microbiol. 28, 1448-1452. doi: 10.1016/j.fm.2011.07.001
3. Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., et al. (2002). Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70, 204-210. doi: 10.1128/IAI.70.1.204-210.2002
4. Bogovazova, G. G., Voroshilova, N. N., and Bondarenko, V. M. (1991). [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection]. Zh. Mikrobiol. Epidemiol. Immunobiol. 4, 5-8.
5. Bogovazova, G. G., Voroshilova, N. N., Bondarenko, V. M., Gorbatkova, G. A., Afanas'eva, E. V., Kazakova, T. B., et al. (1992). [Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages]. Zh. Mikrobiol. Epidemiol. Immunobiol. 30-33.
6. Carlton, R. M. (1999). Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz.) 47, 267-274.
7. Carlton, R. M., Noordman, W. H., Biswas, B., de Meester, E. D., and Loessner, M. J. (2005). Bacteriophage P100 for control of Listeria monocytogenes in foods: Genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul. Toxicol. Pharmacol. 43, 301-312. doi: 10.1016/j.yrtph.2005.08.005
8. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., and Brussow, H. (2004). In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48, 2558-2569. doi: 10.1128/AAC.48.7.2558-2569.2004
9. Chilamban, C., Rawat, M., and Somvanshi, R. (2004). Pre-clinical studies on therapy of Staphylococcus aureus Mastitis by bacteriophage in mice model. Indian J. Comp. Microbiol. Immunol. Infect. Dis. 25, 98-103.
10. Connerton, P. L., Loc Carrillo, C. M., Swift, C., Dillon, E., Scott, A., Rees, C. E., et al. (2004). Longitudinal study of Campylobacter jejuni bacteriophages and their hosts from broiler chickens. Appl. Environ. Microbiol. 70, 3877-3883. doi: 10.1128/AEM.70.7.3877-3883.2004
11. Dini, C., Islan, G. A., de Urrazal, P. J., and Castro, G. R. (2012). Novel biopolymer matrices for microencapsulation of phages: enhanced protection against acidity and protease activity. Macromol. Biosci. 12, 1200-1208. doi: 10.1002/mabi.201200109
12. Fiorentin, L., Vieira, N. D., and Barioni, W. Jr. (2005). Oral treatment with bacteriophages reduces the concentration of Salmonella enteritidis PT4 in caecal contents of broilers. Avian Pathol. 34, 258-263. doi: 10.1080/01445340500112157
13. Garcia, P., Madera, C., Martinez, B., Rodriguez, A., and Evaristo Suarez, J. (2009). Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents. J. Dairy Sci. 92, 3019-3026. doi: 10.3168/jds.2008-1744
14. Geller, B. L., Kraus, J., Schell, M. D., Hornsby, M. J., Neal, J. J., and Ruch, F. E. (1998). High titer, phage-neutralizing antibodies in bovine colostrum that prevent lytic infection of Lactococcus lactis in fermentations of phage-contaminated milk. J. Dairy Sci. 81, 895-900. doi: 10.3168/jds.S0022-0302(98)75648-6
15. Gill, J. J. (2010). "Practical and theoretical considerations for the use of bacteriophages in food systems," in Bacteriophage in the Control of Food-and Waterborne Pathogens, Vol. 11, eds P. M. Sabour and M. W. Griffiths (Washington: ASM Press American Society for Microbiology), 217-235.
16. Gill, J. J., and Hyman, P. (2010). Phage choice, isolation, and preparation for phage therapy. Curr. Pharm. Biotechnol. 11, 2-14. doi: 10.2174/138920110790725311
17. Gill, J. J., Pacan, J. C., Carson, M. E., Leslie, K. E., Griffiths, M. W., and Sabour, P. M. (2006a). Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50, 2912-2918. doi: 10.1128/AAC.01630-05
18. Gill, J. J., Sabour, P. M., Leslie, K. E., and Griffiths, M. W. (2006b). Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K. J. Appl. Microbiol. 101, 377-386. doi: 10.1111/j.1365-2672.2006.02918.x
19. Goode, D., Allen, V. M., and Barrow, P. A. (2003). Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl. Environ. Microbiol. 69, 5032-5036. doi: 10.1128/AEM.69.8.5032-5036.2003
20. Guenther, S., Huwyler, D., Richard, S., and Loessner, M. J. (2009). Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl. Environ. Microbiol. 75, 93-100. doi: 10.1128/AEM.01711-08
21. Hagens, S., and Offerhaus, M. L. (2008). Bacteriophages-new weapons for food safety. Food Technol. 62, 46-54.
22. Higgins, J. P., Andreatti Filho, R. L., Higgins, S. E., Wolfenden, A. D., Tellez, G., and Hargis, B. M. (2008). Evaluation of Salmonella-lytic properties of bacteriophages isolated from commercial broiler houses. Avian Dis. 52, 139-142. doi: 10.1637/8017-050807-ResNote
23. Holck, A., and Berg, J. (2009). Inhibition of Listeria monocytogenes in cooked ham by virulent bacteriophages and protective cultures. Appl. Environ. Microbiol. 75, 6944-6946. doi: 10.1128/AEM.00926-09
24. Hudson, J. A., McIntyre, L., and Billington, C. (2010). "Application of bacteriophages tor control pathogens in food animal production," in Bacteriophage in the Control of Food-and Waterborne Pathogens, Vol. 7, eds P. M. Sabour and M. W. Griffiths (Washington: ASM Press American Society for Microbiology), 119-137.
25. Huff, W. E., Huff, G. R., Rath, N. C., Balog, J. M., and Donoghue, A. M. (2003a). Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis. 47, 1399-1405. doi: 10.1637/7041
26. Huff, W. E., Huff, G. R., Rath, N. C., and Balog, J. M. (2003b). Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. Poult. Sci. 82, 1108-1112.
27. Inal, J. M. (2003). Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. (Warsz.) 51, 237-244.
28. Jamalludeen, N., Johnson, R. P., Shewen, P. E., and Gyles, C. L. (2009). Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs. Vet. Microbiol. 136, 135-141. doi: 10.1016/j.vetmic.2008.10.021
29. Jenny, F. (2011). Fighting bacterial infections-future treatment options. Drug Resist. Updat. 14, 125-139. doi: 10.1016/j.drup.2011.02.001
30. Jonczyk, E., Klak, M., Miedzybrodzki, R., and Gorski, A. (2011). The influence of external factors on bacteriophages-review. Folia Microbiol. (Praha) 56, 191-200. doi: 10.1007/s12223-011-0039-8
31. Kocharunchitt, C., Ross, T., and McNeil, D. L. (2009). Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int. J. Food Microbiol. 128, 453-459. doi: 10.1016/j.ijfoodmicro.2008.10.014
32. Kutateladze, M., and Adamia, R. (2010). Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28, 591-595. doi: 10.1016/j.tibtech.2010.08.001
33. Kutter, E., and Sulakvelidze, A. (2005). "Bacteriophages: biology and applications," in Bacteriophages: Biology and Applications, eds E. Kutter and A. Sulakvelidze, (Boca Raton: CRC Press), 1-5.
34. Langlet, J., Gaboriaud, F., Duval, J. F. L., and Gantzer, C. (2008). Aggregation and surface properties of F-specific RNA phages: implication for membrane filtration processes. Water Res. 42, 2769-2777. doi: 10.1016/j.watres.2008.02.007
35. Ma, Y., Pacan, J. C., Wang, Q., Xu, Y., Huang, X., Korenevsky, A., et al. (2008). Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery. Appl. Environ. Microbiol. 74, 4799-4805. doi: 10.1128/AEM.00246-08
36. Madera, C., Monjardin, C., and Suarez, J. E. (2004). Milk contamination and resistance to processing conditions determine the fate of Lactococcus lactis bacteriophages in dairies. Appl. Environ. Microbiol. 70, 7365-7371. doi: 10.1128/AEM.70.12.7365-7371.2004
37. Mahony, J., McAuliffe, O., Ross, R. P., and van Sinderen, D. (2011). Bacteriophages as biocontrol agents of food pathogens. Curr. Opin. Biotechnol. 22, 157-163. doi: 10.1016/j.copbio.2010.10.008
38. Marco, M. B., Reinheimer, J. A., and Quiberoni, A. (2010). Phage adsorption to Lactobacillus plantarum: influence of physiological and environmental factors. Int. J. Food Microbiol. 138, 270-275. doi: 10.1016/j.ijfoodmicro.2010.01.007
39. Martínez, B., Obeso, J. M., Rodríguez, A., and García, P. (2008). Nisin-bacteriophage crossresistance in Staphylococcus aureus. Int. J. Food Microbiol. 122, 253-258. doi: 10.1016/j.ijfoodmicro.2008.01.011
40. Matsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., et al. (2003). Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187, 613-624. doi: 10.1086/374001
41. Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., et al. (1996). Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. U.S.A. 93, 3188-3192. doi: 10.1073/pnas.93.8.3188
42. Moineau, S., and Fortier, LC. (2009). Phage production and maintenance of stocks, including expected stock lifetimes. Methods Mol. Biol. 501, 203-219. doi: 10.1007/978-1-60327-164-6_19
43. Mylon, S. E., Rinciog, C. I., Schmidt, N., Gutierrez, L., Wong, G. C., and Nguyen, T. H. (2010). Influence of salts and natural organic matter on the stability of bacteriophage MS2. Langmuir 26, 1035-1042. doi: 10.1021/la902290t
44. O'Flaherty, S., Coffey, A., Meaney, W. J., Fitzgerald, G. F., and Ross, R. P. (2005). Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk. Lett. Appl. Microbiol. 41, 274-279. doi: 10.1111/j.1472-765X.2005.01762.x
45. Payne, R. J., and Jansen, V. A. (2001). Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 208, 37-48. doi: 10.1006/jtbi.2000.2198
46. Payne, R. J., Phil, D., and Jansen, V. A. (2000). Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 68, 225-230. doi: 10.1067/mcp.2000.109520
47. Pirnay, J.-P., Verbeken, G., Rose, T., Jennes, S., Zizi, M., Huys, I., et al. (2012). Introducing yesterday's phage therapy in today's medicine. Future Virol. 7, 379-390. doi: 10.2217/fvl.12.24
48. Sulakvelidze, A. (2005). Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov. Today 10, 807-809. doi: 10.1016/S1359-6446(05)03441-0
49. Sulakvelidze, A., Alavidze, Z., and Morris, J. G. Jr. (2001). Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659. doi: 10.1128/AAC.45.3.649-659.2001
50. Wagenaar, J. A., Van Bergen, M. A., Mueller, M. A., Wassenaar, T. M., and Carlton, R. M. (2005). Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet. Microbiol. 109, 275-283. doi: 10.1016/j.vetmic.2005.06.002
51. Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., et al. (2007). Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51, 446-452. doi: 10.1128/AAC.00635-06